Catalent Signs Drug Development Agreement with Cybin Inc for its...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today...(PRWeb March 22, 2021)Read the full story at https://www.prweb.com/releases/catalent_signs_drug_development_agreement_with_cybin_inc_for_its_fast_dissolve_formulation_of_novel_deuterated_tryptamine_cyb003/prweb17810721.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news